siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption

Yuwei Wang1, David W Grainger

  • 1Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah 84112-5820, USA. luckwangyuwei@gmail.com

Abstract

Insights

Small interfering RNA (siRNA) targeting RANK effectively inhibits osteoclast formation and bone resorption. This demonstrates siRNA

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Osteoclasts are crucial for bone remodeling.
  • Dysregulated osteoclast activity contributes to bone pathologies.
  • Targeting cell surface receptors offers therapeutic potential.

Purpose of the Study:

  • To evaluate the efficacy of small interfering RNA (siRNA) targeting the Receptor Activator of Nuclear Factor kappa-B (RANK) in controlling osteoclast function.
  • To assess siRNA's ability to inhibit osteoclast formation and bone resorption in both primary and precursor cell cultures.

Main Methods:

  • Transfection of siRNA targeting RANK into RAW264.7 and primary bone marrow cells.
  • Assessment of RANK knockdown via PCR and Western blot.
  • Evaluation of osteoclast formation using TRAP assay and bone resorption assays.

Main Results:

  • siRNA targeting RANK successfully repressed RANK expression in osteoclast precursors and mature osteoclasts without off-targeting effects.
  • Significant inhibition of osteoclast formation and bone resorption was observed.
  • siRNA demonstrated efficacy in serum-containing media.

Conclusions:

  • RANK is a viable molecular target for siRNA-mediated control of osteoclast activity.
  • siRNA targeting RANK holds promise for developing novel therapeutics for osteoporosis and low bone mass conditions.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...